8-KThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed Jun 3, 2025 · 1y ago · Accession 0001193125-25-133745
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Taysha Gene Therapies, Inc.
- Ticker
- TSHA
- CIK
- 1806310
- Form type
- 8-K
- Filing date
- Jun 3, 2025
- Report date
- Jun 2, 2025
- Document
- d843671d8k.htm
- Size
- 160 KB